Kimberly T Barrett
4PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.David R Martinez, Fernando R Moreira, Nicholas J Catanzaro
|Mar 14, 2024
Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus.Robert W Cross, Courtney Woolsey, Victor C Chu
|Aug 19, 2023
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys.Richard L Mackman, Rao V Kalla, Darius Babusis
|Mar 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.Alexandra Schäfer, David R Martinez, John J Won
Pageof 1
Frequent Collaborators
3 joint publications
Darius Babusis
3 joint publications
John P Bilello
3 joint publications
Roy Bannister
2 joint publications
Alexandra Schäfer
2 joint publications
David R Martinez
2 joint publications
Stephanie A Montgomery
2 joint publications
Richard L Mackman
2 joint publications
Kendra L Gully
2 joint publications
Stephanie Dong
2 joint publications
Joy Y Feng
